Eupraxia Pharmaceuticals (EPRX) EBITDA (2023 - 2025)
Eupraxia Pharmaceuticals (EPRX) posted EBITDA of -$16.64 million for the quarter ended Dec 31, 2025, compared with -$7.48 million a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) EBITDA (2023 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Eupraxia Pharmaceuticals' EBITDA came in at -$38.35 million.
- In prior years, Eupraxia Pharmaceuticals' EBITDA was -$26.17 million in the year ended Dec 31, 2024, -$29.94 million in the year ended Dec 31, 2023 and -$19.83 million in the year ended Dec 31, 2022.
- The figure for the quarter ended Dec 31, 2025 stands as the lowest quarterly EBITDA in data going back to the quarter ended Mar 31, 2023.
- According to Business Quant data, EBITDA for the three prior quarters was -$6.31 million (quarter ended Sep 30, 2025), -$8.69 million (quarter ended Jun 30, 2025) and -$6.72 million (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Eupraxia Pharmaceuticals | 308.46 Mn | -133.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -16.64 Mn |
| Sep 30, 2025 | -6.31 Mn |
| Jun 30, 2025 | -8.69 Mn |
| Mar 31, 2025 | -6.72 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Sep 30, 2024 | -5.95 Mn |
| Jun 30, 2024 | -6.31 Mn |
| Mar 31, 2024 | -6.44 Mn |
| Jun 30, 2023 | -9.77 Mn |
| Mar 31, 2023 | -4.21 Mn |
API Access
Eupraxia Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();